{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:09:01Z","timestamp":1771423741323,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15602-5","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T04:34:43Z","timestamp":1769142883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative single-cell and machine-learning analysis identifies ac4C-related S100A13 as a causal risk gene in cholangiocarcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Yi","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"9","key":"15602_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557\u201388. https:\/\/doi.org\/10.1038\/s41575-020-0310-z.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"15602_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI, et al. Cholangiocarcinoma. Nat Rev Dis Primers. 2021;7(1):65. https:\/\/doi.org\/10.1038\/s41572-021-00300-2.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"15602_CR3","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1002\/cncr.32803","volume":"126","author":"AA Florio","year":"2020","unstructured":"Florio AA, Ferlay J, Znaor A, et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer. 2020;126(11):2666\u201378. https:\/\/doi.org\/10.1002\/cncr.32803.","journal-title":"Cancer"},{"issue":"9","key":"15602_CR4","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.ejso.2019.04.002","volume":"45","author":"E Alabraba","year":"2019","unstructured":"Alabraba E, Joshi H, Bird N, et al. Increased multimodality treatment options has improved survival for hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged. Eur J Surg Oncol. 2019;45(9):1660\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2019.04.002.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"15602_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/SLA.0000000000003801","volume":"273","author":"WA Cambridge","year":"2021","unstructured":"Cambridge WA, Fairfield C, Powell JJ, et al. Meta-analysis and Meta-regression of survival after liver transplantation for unresectable Perihilar cholangiocarcinoma. Ann Surg. 2021;273(2):240\u201350. https:\/\/doi.org\/10.1097\/SLA.0000000000003801.","journal-title":"Ann Surg"},{"issue":"10272","key":"15602_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021;397(10272):428\u201344. https:\/\/doi.org\/10.1016\/S0140-6736(21)00153-7.","journal-title":"Lancet"},{"issue":"9935","key":"15602_CR7","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ, Cholangiocarcinoma. Lancet. 2014;383(9935):2168\u201379. https:\/\/doi.org\/10.1016\/S0140-6736(13)61903-0.","journal-title":"Lancet"},{"issue":"8","key":"15602_CR8","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1136\/gutjnl-2022-327099","volume":"71","author":"RIR Macias","year":"2022","unstructured":"Macias RIR, Cardinale V, Kendall TJ, et al. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions. Gut. 2022;71(8):1669\u201383. https:\/\/doi.org\/10.1136\/gutjnl-2022-327099.","journal-title":"Gut"},{"key":"15602_CR9","doi-asserted-by":"publisher","unstructured":"Liu CX, Wong CC. Stratifying cholangiocarcinoma: tumor Microenvironment, molecular Drivers, and novel immunotherapeutic approaches. Clin Mol Hepatol.\u00a02025;14. https:\/\/doi.org\/10.3350\/cmh.2025.0889.","DOI":"10.3350\/cmh.2025.0889"},{"key":"15602_CR10","doi-asserted-by":"publisher","unstructured":"Zhu L, Cheung YM, Chiang C et al. Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors. J Immunother Cancer. 2025;13(10):e011865. https:\/\/doi.org\/10.1136\/jitc-2025-011865\u00a0.","DOI":"10.1136\/jitc-2025-011865"},{"issue":"42","key":"15602_CR11","doi-asserted-by":"publisher","first-page":"e2509222122","DOI":"10.1073\/pnas.2509222122","volume":"122","author":"J Xie","year":"2025","unstructured":"Xie J, Shen K, Liang W, et al. Protein disulfide isomerases regulate androgen receptor stability and promote prostate cancer cell growth and survival. Proc Natl Acad Sci U S A. 2025;122(42):e2509222122. https:\/\/doi.org\/10.1073\/pnas.2509222122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15602_CR12","doi-asserted-by":"publisher","unstructured":"Minini M, Avveduto G, Becharef S, et al. Laser-activated nanoparticles rewire tumor microenvironment enhancing PD-1 Blockade and T cell response in cholangiocarcinoma. Hepatol. 2025;2. https:\/\/doi.org\/10.1097\/HEP.0000000000001545.","DOI":"10.1097\/HEP.0000000000001545"},{"issue":"1","key":"15602_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13062-025-00687-y","volume":"20","author":"T Lomphithak","year":"2025","unstructured":"Lomphithak T, Duangthim N, Sonkaew S, Jitkaew S. Necroptosis-driven T cell activation promotes IL-6-mediated PD-L1 upregulation in cholangiocarcinoma cells: IL-6 gene signature as a biomarker for chemo-immunotherapy response. Biol Direct. 2025;20(1):98. https:\/\/doi.org\/10.1186\/s13062-025-00687-y.","journal-title":"Biol Direct"},{"key":"15602_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4103\/jrms.jrms_705_22","volume":"30","author":"CMA Savitri","year":"2025","unstructured":"Savitri CMA, Rahmawati LD, Awalia, et al. Epigenetic alterations in Helicobacter pylori infection leading to gastric carcinogenesis: A systematic review. J Res Med Sci. 2025;30:50. https:\/\/doi.org\/10.4103\/jrms.jrms_705_22.\u00a0","journal-title":"J Res Med Sci"},{"issue":"1","key":"15602_CR15","doi-asserted-by":"publisher","first-page":"101672","DOI":"10.1016\/j.gendis.2025.101672","volume":"13","author":"H Liu","year":"2025","unstructured":"Liu H, Song T, Huang Y. The mechanism of m6A modification in cardiovascular diseases: A systematic review. Genes Dis. 2025;13(1):101672. https:\/\/doi.org\/10.1016\/j.gendis.2025.101672.\u00a0","journal-title":"Genes Dis"},{"key":"15602_CR16","doi-asserted-by":"publisher","first-page":"1693336","DOI":"10.3389\/fimmu.2025.1693336","volume":"16","author":"X Chen","year":"2025","unstructured":"Chen X, Pu S, Lian K, Li L, Jiang X. m6A RNA modification in tumor-associated macrophages: emerging roles in cancer immunity. Front Immunol. 2025;16:1693336. https:\/\/doi.org\/10.3389\/fimmu.2025.1693336.","journal-title":"Front Immunol"},{"key":"15602_CR17","doi-asserted-by":"publisher","unstructured":"Li C, Jiang X, Jia Y, Zhou Q, Yuan Y, Wang Q. The critical role of NAT10-mediated N4-acetylcytidine modification in tumor immunity. Front Immunol. 2025;16(1695495). https:\/\/doi.org\/10.3389\/fimmu.2025.1695495.\u00a0","DOI":"10.3389\/fimmu.2025.1695495"},{"key":"15602_CR18","doi-asserted-by":"publisher","unstructured":"Eleftheriou M, Russell J, Tzelepis K. Epitranscriptomic advances in normal and malignant hematopoiesis. Leuk. 2025;19. https:\/\/doi.org\/10.1038\/s41375-025-02765-6.","DOI":"10.1038\/s41375-025-02765-6"},{"key":"15602_CR19","doi-asserted-by":"publisher","first-page":"1623276","DOI":"10.3389\/fcell.2025.1623276","volume":"13","author":"D Qin","year":"2025","unstructured":"Qin D, Liu Q, Ma X, et al. Research progress on NAT10-mediated acetylation in normal development and disease. Front Cell Dev Biol. 2025;13:1623276. https:\/\/doi.org\/10.3389\/fcell.2025.1623276.\u00a0","journal-title":"Front Cell Dev Biol"},{"key":"15602_CR20","doi-asserted-by":"publisher","first-page":"1633699","DOI":"10.3389\/fonc.2025.1633699","volume":"15","author":"R Shi","year":"2025","unstructured":"Shi R, Cao Z, Li J, Ji R, Guo Z. Targeting the Wnt\/\u03b2-catenin pathway and epithelial-mesenchymal transition in gastric cancer: mechanisms, therapeutic strategies, and clinical challenges. Front Oncol. 2025;15:1633699. https:\/\/doi.org\/10.3389\/fonc.2025.1633699.\u00a0","journal-title":"Front Oncol"},{"key":"15602_CR21","doi-asserted-by":"publisher","unstructured":"Peng X, Li P, Zhang Y, Zhang Q, Liang W. Aging increases susceptibility to liver fibrosis through enhanced NAT10-mediated ac4C modification of TGF\u03b21 mRNA. Genome Med. 2025;17(1):90. https:\/\/doi.org\/10.1186\/s13073-025-01520-x","DOI":"10.1186\/s13073-025-01520-x"},{"key":"15602_CR22","doi-asserted-by":"publisher","unstructured":"Jiao L, Si Y, Yuan Y et al. Emerging role of N-acetyltransferase 10 in diseases: RNA ac4C modification and beyond. Mol Biomed. 2025;6(1):46. https:\/\/doi.org\/10.1186\/s43556-025-00286-3","DOI":"10.1186\/s43556-025-00286-3"},{"issue":"11","key":"15602_CR23","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.7150\/ijbs.113325","volume":"21","author":"X Lei","year":"2025","unstructured":"Lei X, Zheng B, Peng Y, et al. Targeting the NAT10\/XIST\/YAP1 Axis-Mediated vascular abnormalization enhances immune checkpoint Blockade in gastric cancer. Int J Biol Sci. 2025;21(11):4997\u20135014. https:\/\/doi.org\/10.7150\/ijbs.113325.\u00a0","journal-title":"Int J Biol Sci"},{"issue":"Pt 2","key":"15602_CR24","doi-asserted-by":"publisher","first-page":"146767","DOI":"10.1016\/j.ijbiomac.2025.146767","volume":"322","author":"D Yang","year":"2025","unstructured":"Yang D, Yun Y, Ma Y, et al. Integrative multi-omics analysis N4-acetylcytidine modification landscape and the role of TMEM65 in breast cancer. Int J Biol Macromol. 2025;322(Pt 2):146767. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146767.","journal-title":"Int J Biol Macromol"},{"key":"15602_CR25","doi-asserted-by":"publisher","first-page":"139823","DOI":"10.1016\/j.ijbiomac.2025.139823","volume":"297","author":"N Xiao","year":"2025","unstructured":"Xiao N, Liu H, Zhang R, et al. N-acetyltransferase 10 impedes EZH2\/H3K27me3\/GABARAP axis mediated autophagy and facilitates lung cancer tumorigenesis through enhancing SGK2 mRNA acetylation. Int J Biol Macromol. 2025;297:139823. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.139823.","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"15602_CR26","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","volume":"73","author":"M Zhang","year":"2020","unstructured":"Zhang M, Yang H, Wan L, et al. Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma. J Hepatol. 2020;73(5):1118\u201330. https:\/\/doi.org\/10.1016\/j.jhep.2020.05.039.","journal-title":"J Hepatol"},{"issue":"5","key":"15602_CR27","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00428-024-03922-5","volume":"485","author":"G Lubuela","year":"2024","unstructured":"Lubuela G, Beaufr\u00e8re A, Albuquerque M, et al. Prognostic impact of the tumour microenvironment in intrahepatic cholangiocarcinoma: identification of a peritumoural fibro-immune interface. Virchows Arch. 2024;485(5):901\u201311. https:\/\/doi.org\/10.1007\/s00428-024-03922-5.","journal-title":"Virchows Arch"},{"issue":"4","key":"15602_CR28","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s12072-019-09954-3","volume":"13","author":"KS Ahn","year":"2019","unstructured":"Ahn KS, O\u2019Brien D, Kang YN, et al. Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular-clinical analysis and potential targeted approach. Hepatol Int. 2019;13(4):490\u2013500. https:\/\/doi.org\/10.1007\/s12072-019-09954-3.","journal-title":"Hepatol Int"},{"issue":"W1","key":"15602_CR29","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u201360. https:\/\/doi.org\/10.1093\/nar\/gkz430.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"15602_CR30","doi-asserted-by":"publisher","first-page":"e15070","DOI":"10.1111\/exd.15070","volume":"33","author":"J Xie","year":"2024","unstructured":"Xie J, Wu D, Zhang P, Zhao S, Qi M. Deciphering cutaneous melanoma prognosis through LDL metabolism: Single-cell transcriptomics analysis via 101 machine learning algorithms. Exp Dermatol. 2024;33(4):e15070. https:\/\/doi.org\/10.1111\/exd.15070.","journal-title":"Exp Dermatol"},{"issue":"1","key":"15602_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","volume":"20","author":"S Jin","year":"2025","unstructured":"Jin S, Plikus MV, Nie Q. CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics. Nat Protoc. 2025;20(1):180\u2013219. https:\/\/doi.org\/10.1038\/s41596-024-01045-4.","journal-title":"Nat Protoc"},{"issue":"4","key":"15602_CR32","doi-asserted-by":"publisher","first-page":"e13409","DOI":"10.1111\/cpr.13409","volume":"56","author":"N Zhang","year":"2023","unstructured":"Zhang N, Zhang H, Liu Z, et al. An artificial intelligence network-guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms. Cell Prolif. 2023;56(4):e13409. https:\/\/doi.org\/10.1111\/cpr.13409.","journal-title":"Cell Prolif"},{"issue":"1","key":"15602_CR33","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu L, Weng S, et al. Machine learning-based integration develops an immune-derived LncRNA signature for improving outcomes in colorectal cancer. Nat Commun. 2022;13(1):816. https:\/\/doi.org\/10.1038\/s41467-022-28421-6.\u00a0","journal-title":"Nat Commun"},{"key":"15602_CR34","doi-asserted-by":"publisher","unstructured":"Angel A, Naom L, Nabet-Levy S, Aran D. xCell 2.0: robust algorithm for cell type proportion estimation predicts response to immune checkpoint blockade. Genome Biol. 2025;26(1):335. https:\/\/doi.org\/10.1186\/s13059-025-03784-3.","DOI":"10.1186\/s13059-025-03784-3"},{"key":"15602_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-1-0716-0327-7_17","volume":"2120","author":"J Racle","year":"2020","unstructured":"Racle J, Gfeller D. EPIC: A tool to estimate the proportions of different cell types from bulk gene expression data. Methods Mol Biol. 2020;2120:233\u201348. https:\/\/doi.org\/10.1007\/978-1-0716-0327-7_17.","journal-title":"Methods Mol Biol"},{"key":"15602_CR36","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. https:\/\/doi.org\/10.1038\/ncomms3612.","journal-title":"Nat Commun"},{"key":"15602_CR37","doi-asserted-by":"publisher","first-page":"108198","DOI":"10.1016\/j.compbiomed.2024.108198","volume":"171","author":"H Gong","year":"2024","unstructured":"Gong H, Liu Z, Yuan C, et al. Identification of cuproptosis-related LncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma. Comput Biol Med. 2024;171:108198. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108198.","journal-title":"Comput Biol Med"},{"issue":"9","key":"15602_CR38","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1093\/bioinformatics\/btac122","volume":"38","author":"X Li","year":"2022","unstructured":"Li X, Li M, Xiang J, Zhao Z, Shang X. SEPA: signaling entropy-based algorithm to evaluate personalized pathway activation for survival analysis on pan-cancer data. Bioinformatics. 2022;38(9):2536\u201343. https:\/\/doi.org\/10.1093\/bioinformatics\/btac122.","journal-title":"Bioinformatics"},{"key":"15602_CR39","doi-asserted-by":"publisher","first-page":"9436238","DOI":"10.1155\/2024\/9436238","volume":"1","author":"PS Ramalingam","year":"2024","unstructured":"Ramalingam PS, Raj DBTG, Subramanian M, Arumugam S. ML-Based screening of MiRNA inhibitors and intervention of lncRNA\/miRNA\/mRNA axis in oncogenic KRAS\u2010Associated colorectal cancer. Adv Public Health. 2024;1:9436238. https:\/\/doi.org\/10.1155\/2024\/9436238.","journal-title":"Adv Public Health"},{"issue":"6","key":"15602_CR40","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/08923973.2024.2402338","volume":"46","author":"Y He","year":"2024","unstructured":"He Y, Fan Z, Sun W, Ouyang L, Wang C. Clinical features, treatment, and outcome of nivolumab-induced cholangitis. Immunopharmacol Immunotoxicol. 2024;46(6):757\u201362. https:\/\/doi.org\/10.1080\/08923973.2024.2402338.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"4","key":"15602_CR41","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.21037\/tcr.2020.03.03","volume":"9","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Hu F, Li M, et al. Interaction between linc01615 and miR-491-5p regulates the survival and metastasis of colorectal cancer cells. Transl Cancer Res. 2020;9(4):2638\u201347. https:\/\/doi.org\/10.21037\/tcr.2020.03.03.","journal-title":"Transl Cancer Res"},{"key":"15602_CR42","doi-asserted-by":"publisher","unstructured":"Huang Y, Liang B, Yu N, et al. NAT10 regulates the Migration, Invasion, and angiogenesis of human umbilical vein endothelial cells through ac4C modification of MEOX2 in gestational diabetes mellitus. Appl Biochem Biotechnol. 2025;13. https:\/\/doi.org\/10.1007\/s12010-025-05416-9.","DOI":"10.1007\/s12010-025-05416-9"},{"issue":"1","key":"15602_CR43","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s41065-025-00555-9","volume":"162","author":"L Liu","year":"2025","unstructured":"Liu L, Chen Q, Li Y, Wu W, Jiang F, Qiu H. The FOXD1\/NAT10 positive feedback loop drives nasopharyngeal carcinoma progression. Hereditas. 2025;162(1):186. https:\/\/doi.org\/10.1186\/s41065-025-00555-9.","journal-title":"Hereditas"},{"issue":"9","key":"15602_CR44","doi-asserted-by":"publisher","first-page":"e70496","DOI":"10.1002\/jbt.70496","volume":"39","author":"C Wang","year":"2025","unstructured":"Wang C, Liu J, Chang H, et al. NAT10-Mediated N4-Acetylation of SLC7A11 mRNA promotes hepatocellular carcinoma progression and metastasis by repressing ferroptosis. J Biochem Mol Toxicol. 2025;39(9):e70496. https:\/\/doi.org\/10.1002\/jbt.70496.","journal-title":"J Biochem Mol Toxicol"},{"key":"15602_CR45","doi-asserted-by":"publisher","unstructured":"Yan Y, Liu S, Wen J et al. Advances in RNA-based cancer therapeutics: pre-clinical and clinical implications. Mol Cancer. 2025;24(1):251. https:\/\/doi.org\/10.1186\/s12943-025-02463-y","DOI":"10.1186\/s12943-025-02463-y"},{"key":"15602_CR46","doi-asserted-by":"publisher","unstructured":"Yan Q, Xu C, Gong L et al. The role of ZC3H13 in promoting M2 macrophage infiltration via m6A methylation in esophageal squamous cell carcinoma tumor progression. Front Immunol. 2025;16:1612041. https:\/\/doi.org\/10.3389\/fimmu.2025.1612041","DOI":"10.3389\/fimmu.2025.1612041"},{"key":"15602_CR47","doi-asserted-by":"publisher","first-page":"113664","DOI":"10.1016\/j.jconrel.2025.113664","volume":"382","author":"J Yang","year":"2025","unstructured":"Yang J, Zhu J, Lu S, Qin H, Zhou W. Transdermal psoriasis treatment inspired by tumor microenvironment-mediated Immunomodulation and advanced by Exosomal engineering. J Control Release. 2025;382:113664. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113664.","journal-title":"J Control Release"},{"key":"15602_CR48","doi-asserted-by":"publisher","unstructured":"Tang L, Wang Y, Gong X et al. Integrated transcriptome and metabolome analysis to investigate the mechanism of intranasal insulin treatment in a rat model of vascular dementia. Front Pharmacol. 2023;14:1182803. https:\/\/doi.org\/10.3389\/fphar.2023.1182803","DOI":"10.3389\/fphar.2023.1182803"},{"key":"15602_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ymeth.2021.08.001","volume":"198","author":"XY Li","year":"2022","unstructured":"Li XY, Xiang J, Wu FX, Li M, NetAUC. A network-based multi-biomarker identification method by AUC optimization. Methods. 2022;198:56\u201364. https:\/\/doi.org\/10.1016\/j.ymeth.2021.08.001.","journal-title":"Methods"},{"key":"15602_CR50","doi-asserted-by":"publisher","unstructured":"Cao X, Lang S, Xie Y, Zheng K, Liu J. Matrix gla protein mediates CD8\u2009+\u2009T-cell exhaustion to facilitate immune evasion in intrahepatic cholangiocarcinoma. Cytojournal. 2025;22:41.\u00a0https:\/\/doi.org\/10.25259\/Cytojournal_232_2024","DOI":"10.25259\/Cytojournal_232_2024"},{"key":"15602_CR51","doi-asserted-by":"publisher","unstructured":"Sun Q, Dong C. Regulators of CD8\u2009+\u2009T cell exhaustion. Nat Rev Immunol. 2025;1. https:\/\/doi.org\/10.1038\/s41577-025-01221-x.","DOI":"10.1038\/s41577-025-01221-x"},{"issue":"4","key":"15602_CR52","doi-asserted-by":"publisher","first-page":"e14489","DOI":"10.1111\/cns.14489","volume":"30","author":"WW Duan","year":"2024","unstructured":"Duan WW, Yang LT, Liu J, et al. A TGF-\u03b2 signaling-related LncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response. CNS Neurosci Ther. 2024;30(4):e14489. https:\/\/doi.org\/10.1111\/cns.14489.","journal-title":"CNS Neurosci Ther"},{"key":"15602_CR53","doi-asserted-by":"publisher","unstructured":"Aruquipa MPS. Mechanisms of resistance to FGFR inhibitors in the treatment of advanced cholangiocarcinoma with FGFR mutations: A literature review. Cancer Plus, 7525.https:\/\/doi.org\/10.36922\/cp.7525","DOI":"10.36922\/cp.7525"},{"key":"15602_CR54","doi-asserted-by":"publisher","first-page":"1107128","DOI":"10.3389\/fmed.2023.1107128","volume":"10","author":"PS Ramalingam","year":"2023","unstructured":"Ramalingam PS, Priyadharshini A, Emerson IA, Arumugam S. Potential biomarkers uncovered by bioinformatics analysis in Sotorasib resistant-pancreatic ductal adenocarcinoma. Front Med (Lausanne). 2023;10:1107128. https:\/\/doi.org\/10.3389\/fmed.2023.1107128.","journal-title":"Front Med (Lausanne)"},{"key":"15602_CR55","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408. https:\/\/doi.org\/10.7554\/eLife.34408.\u00a0","journal-title":"Elife"},{"issue":"2","key":"15602_CR56","doi-asserted-by":"publisher","first-page":"12003","DOI":"10.1080\/21655979.2021.2002494","volume":"12","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Li J, Yang X, Song Y, Li H. Rhophilin Rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha (TOP2A). Bioengineered. 2021;12(2):12003\u201322. https:\/\/doi.org\/10.1080\/21655979.2021.2002494.","journal-title":"Bioengineered"},{"issue":"1","key":"15602_CR57","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41698-025-01125-y","volume":"9","author":"XJ Cai","year":"2025","unstructured":"Cai XJ, Peng CR, Ding CY, et al. Tumor cell- and infiltrating immune cell-based supervised learning artificial intelligence multimodal platform for tumor prognosis. NPJ Precis Oncol. 2025;9(1):348. https:\/\/doi.org\/10.1038\/s41698-025-01125-y.\u00a0","journal-title":"NPJ Precis Oncol"},{"key":"15602_CR58","doi-asserted-by":"publisher","unstructured":"Kuang J, Zhong G, Zhao L, Yuan X, Zhou Y, Li J. Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer. NPJ Digit Med. 2025;8(1):565. https:\/\/doi.org\/10.1038\/s41746-025-01967-7.","DOI":"10.1038\/s41746-025-01967-7"},{"issue":"1","key":"15602_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41540-025-00513-1","volume":"11","author":"C Li","year":"2025","unstructured":"Li C, Wei Y, Lei J. Quantitative cancer-immunity cycle modeling for predicting disease progression in advanced metastatic colorectal cancer. NPJ Syst Biol Appl. 2025;11(1):33. https:\/\/doi.org\/10.1038\/s41540-025-00513-1.\u00a0","journal-title":"NPJ Syst Biol Appl"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15602-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15602-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15602-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:28:00Z","timestamp":1771421280000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15602-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15602"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15602-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). All animal experiments were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of The First Affiliated Hospital of Zhejiang University School of Medicine (Approval No. 2025\u2009\u2212\u2009227). All methods were carried out in accordance with relevant guidelines and regulations. All methods are reported in accordance with ARRIVE guidelines (\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}